Effect of moderately high dietary salt and lipoic acid on blood pressure in Wistar-Kyoto rats

Experimental and Clinical Cardiology

Volumn 12, Issue 2, 2007, Pages 77-81

  Vasdev, Sudesh ^a   Gill, Vicki D ^a   Parai, Sushil ^a   Gadag, Veeresh ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Aldehydes; Blood pressure; Lipoic acid; Moderately high salt

Indexed keywords

ALDEHYDE; CALCIUM; SODIUM CHLORIDE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CALCIUM CELL LEVEL; CHEMOSENSITIVITY; CONTROLLED STUDY; CYTOSOL; GLUCOSE METABOLISM; INSULIN RESISTANCE; KIDNEY BLOOD VESSEL; NONHUMAN; RAT; SALT INTAKE; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE; WISTAR KYOTO RAT;

EID: 34447284767     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. González-Albarrán O, Ruilope LM, Villa E, Robles RG. Salt sensitivity: Concept and pathogenesis. Diabetes Res Clin Pract 1998;Suppl 39:S15-26.
2. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986;8:II127-34.
3. Preuss MB, Preuss HG. The effects of sucrose and sodium on blood pressures in various substrains of Wistar rats. Lab Invest 1980;43:101-7.
4. Kotchen TA, Zhang HY, Covelli M, Blehschmidt N. Insulin resistance and blood pressure in Dahl rats and in one-kidney, one-clip hypertensive rats. Am J Physiol 1991;261:E692-7.
5. Vasdev S, Gill V, Longerich L, Parai S, Gadag V. Salt-induced hypertension in WKY rats: Prevention by alpha-lipoic acid supplementation. Mol Cell Biochem 2003;254:319-26.
6. Vasdev S, Gill V, Parai S, Gadag V. Dietary vitamin e supplementation attenuates hypertension in Dahl salt-sensitive rats. J Cardiovasc Pharmacol Thera 2005;10:103-11.
7. Vasdev S, Gill V, Parai S, Gadag V. Dietary lipoic acid supplementation attenuates hypertension in Dahl salt sensitive rats. Mol Cell Biochem 2005;275:135-41.
8. Fuenmayor N, Moreira E, Cubeddu LX. Salt sensitivity is associated with insulin resistance in essential hypertension. Am J Hypertens 1998;4:397-402.
9. Ogihara T, Asano T, Ando K, et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 2002;40:83-9.
10. Ogihara T, Asano T, Fujita T. Contribution of salt intake to insulin resistance associated with hypertension. Life Sci 2003;73:509-23.
11. Donovan DS, Solomon CG, Seely EW, Williams GH, Simonson DC. Effect of sodium intake on insulin sensitivity. Am J Physiol 1993;264:E730-4.
12. Sechi LA. Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity. J Hypertens 1999;17:1229-37.
13. Giner V, Coca A, de la Sierra A. Increased insulin resistance in salt sensitive essential hypertension. J Hum Hypertens 2001;15:481-5.
14. Vasdev S, Gill V, Longerich L. Role of methylglyoxal in essential hypertension. In: SK Gupta, ed. Pharmacotherapy of Heart Failure. New Delhi, India: Anamaya Publishers, 2004:72-88.
15. Panel on Dietary Reference Intakes for Electrolytes and Water, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. National Academies of Science. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate, 2004. (Version current at February 5, 2007).
16. Vasdev S, Mian T, Ford CA, Longerich L, Parai S. Role of endogenous aldehydes in spontaneously hypertensive and disulfiram-induced hypertensive rats. Nutr Metab Cardiovasc Dis 1996;6:130-40.
17. Dillard CJ, Tappel AL. Fluorescent damage products of lipid peroxidation. Methods Enzymol 1984;105:337-41.
18. Mandal AK, Bell RD, Parker D, Nordquist JA, Lindeman RD. An analysis of the relationship of malignant lesions of the kidney to hypertension. Microvasc Res 1977;14:279-92.
19. World Health Organization. Global strategy on diet, physical activity and health: Chronic disease risk factors. 2004. (Version current at February 5, 2007).
20. Jacobson MF. Salt: The forgotten killer. Center for Science in the Public Interest, 2005. (Version current at February 5, 2007).
21. American Heart Association. Recommendations for dietary sodium intake, 2007. (Version current at February 5, 2007).
22. Muntzel M, Drueke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens 1992;5:1S-42S.
23. Cubeddu LX, Alfieri AB, Hoffmann IS, et al. Nitric oxide and salt sensitivity. Am J Hypertens 2000;13:973-9.
24. Bayorh MA, Ganada AA, Socci RR, Silvestrov N, Abukhalaf IK. The role of oxidative stress in salt-induced hypertension. Am J Hypertens 2004;17:31-6.
25. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;313:350-7.
26. Reaven GM. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 1991;90:7S-12S.
27. Garvey WT, Birnbaum MJ. Cellular insulin action and insulin resistance. Baillieres Clin Endocrinol Metab 1993;7:785-873.
28. Falcon C, Pfliegler G, Deckmyn H, Vermylen J. The platelet insulin receptor: Detection, partial characterization, and search for a function. Biochem Biophys Res Commun 1988;157:1190-6.
29. Sechi LA, Griffin CA, Schambelan M. Effect of dietary sodium chloride on insulin receptor number and mRNA levels in rat kidney. Am J Physiol 1994;266:F31-8.
30. Thornalley PJ. Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies. Biochem Soc Trans 1993;21:531-4.
31. Beisswenger PJ, Howell SK, Smith K, Szwergold B. Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 2003;1637:98-106.
32. Thorpe SR, Baynes JW. Maillard reaction products in tissue proteins: New products and new perspectives. Amino Acids 2003;25:275-81.
33. Zeng J, Davies MJ. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chem Res Toxicol 2005;18:1232-41.
34. Degenhardt TP, Thorpe SR, Baynes JW. Chemical modification of proteins by methylglyoxal. Cell Mol Biol (Noisy-le-grand) 1998;44:1139-45.
35. Morgan PE, Dean RT, Davies MJ. Inactivation of cellular enzymes by carbonyls and protein-bound glycation/glycoxidation products. Arch Biochem Biophys 2002;403:259-69.
36. Nagaraj RH, Sarkar P, Mally A, Biemel KM, Lederer MO, Padayatti PS. Effect of pyridoxamine on chemical modification of protein by carbonyls in diabetic rats: Characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch Biochem Biophys 2002;402:110-9.
37. Karachalias N, Babaei-Jadidi R, Ahmed N, Thornalley PJ. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rat. Biochem Soc Trans 2003;31:1423-5.
38. Bidasee KR, Nallani K, Yu Y, et al. Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels. Diabetes 2003;52:1825-36.
39. Horiuchi S, Sakamoto Y, Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids 2003;25:283-92.
40. Verbeke P, Perichon M, Friguet B, Bakala H. Inhibition of nitric oxide synthase activity by early and advanced glycation end products in cultured rabbit proximal tubular epithelial cells. Biochim Biophys Acta 2000;1502:481-94.
41. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 2003;21:3-12.
42. Scivitarro V, Ganz MB, Weiss MF. AGEs induce oxidative stress and activate protein kinase C-β-II in neonatal mesangial cells. Am J Physiol Renal Physiol 2000;278:F676-83.
43. Vasdev S, Ford CA, Longerich L, Parai S, Gadag V, Wadhawan S. Aldehyde induced hypertension in rats: Prevention by N-acetylcysteine. Artery 1998;23:10-36.
44. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary lipoic acid supplementation prevents fructose-induced hypertension in rats. Nutr Metab Cardiovasc Dis 2000;10:339-46.
45. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V. Dietary alpha-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J Hypertens 2000;18:567-73.
46. Midaoui AE, Elimadi A, Wu L, Haddad PS, de Champlain J. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production. Am J Hypertens 2003;16:173-9.
47. Wang X, Desai K, Clausen JT, Wu L. Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats. Kidney Int 2004;66:2315-21.
48. Vasdev S, Gill V, Longerich L. Antihypertensive effect of alpha lipoic acid supplementation. Curr Top Nutraceut Res 2004;2:137-52.
49. Yamamoto Y, Kato I, Doi T, et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 2001;108:261-8.
50. Johnson RJ, Herrara-Acosta J, Schreuner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypetension. N Engl J Med 2002;346:913-23.
51. Center for Disease Control. Dietary intake of macronutrients, micronutrients, and other dietary constituents: United States, 1988-94. Vital Health and Statistics Report, 2002. (Version current at February 5, 2007).
52. Packer L, Roy S, Sen CK. Alpha-lipoic acid: A metabolic antioxidant and potential redox modulator of transcription. Adv Pharmacol 1997;38:79-101.
53. Kocak G, Aktan F, Canbolat O, et al. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin. Diabetes Nutr Metab 2000;13:308-18.
54. Busse E, Zimmer G, Schopohl B, Kornhuber B. Influence of alphalipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung 1992;42:829-31.
55. Jacob S, Ruus P, Herman R, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: A placebo-controlled pilot trial. Free Radic Biol Med 1999;27:309-14.
56. Konrad T, Vicini P, Kusterer K, et al. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care 1999;22:280-7.
57. Morcos M, Borcea V, Isermann, Gehrke S, et al. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: An exploratory study. Diabetes Res Clin Pract 2001;52:175-83.
58. Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Marie C. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int 2005;67:1371-80.